Stay updated with breaking news from Memoryt Cells. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FOR IMMEDIATE RELEASE: Compugen Selected for two Oral Presentations at the Keystone Symposium on Cancer Immunotherapy ...
- Phase 2 Mechanism of Action Trial Results Demonstrate the Immunomodulatory Effects of Trilaciclib in the Tumor Microe...
Infants have a high proportion of naive T cells and as they move towards adulthood, they get exposed to to more viruses, the naive T cells are replaced by memory T cells
Findings on the mechanism of action from the BOXR CAR-T platform indicate improved metabolic function and preservation of early memory subsets of T cells SOTIO anticipates initiating first-in-human DUET-01 trial for lead CAR-T cell therapy candidate, BOXR1030, in coming monthsPhase 2 AURELIO-04 combination study of...
Expression of PD-1 on Memory T Lymphocytes Predicts 28-Day Mortality of Patients with Sepsis: A Prospective Observational Study